Moleculin Biotech, Inc. (MBRX)

NASDAQ: MBRX · Real-Time Price · USD

0.9591

-0.0145 (-1.49%)

At close: Apr 1, 2025, 4:00 PM

0.9496

-0.0095 (-0.99%)

After-hours: Apr 1, 2025, 5:01 PM EDT

Moleculin Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Selling, General & Admin	8.79	10.02	11.54	8.39	6.79	Upgrade
Research & Development	17.73	19.49	18.97	14.42	12.76	Upgrade
Operating Expenses	26.64	29.63	30.64	22.97	19.74	Upgrade
Operating Income	-26.64	-29.63	-30.64	-22.97	-19.74	Upgrade
Interest & Investment Income	0.55	1.37	0.24	0.31	0.01	Upgrade
Other Non Operating Income (Expenses)	4.33	-1.51	1.38	6.77	2.37	Upgrade
EBT Excluding Unusual Items	-21.76	-29.77	-29.03	-15.89	-17.36	Upgrade
Pretax Income	-21.76	-29.77	-29.03	-15.89	-17.36	Upgrade
Net Income	-21.76	-29.77	-29.03	-15.89	-17.36	Upgrade
Net Income to Common	-21.76	-29.77	-29.03	-15.89	-17.36	Upgrade
Shares Outstanding (Basic)	3	2	2	2	1	Upgrade
Shares Outstanding (Diluted)	3	2	2	2	1	Upgrade
Shares Change (YoY)	74.28%	3.60%	6.43%	172.97%	45.07%	Upgrade
EPS (Basic)	-6.32	-15.07	-15.22	-8.87	-26.44	Upgrade
EPS (Diluted)	-6.32	-15.07	-15.22	-8.87	-26.44	Upgrade
Free Cash Flow	-23.88	-23.72	-27.71	-18.97	-18.15	Upgrade
Free Cash Flow Per Share	-6.93	-12.00	-14.53	-10.59	-27.65	Upgrade
EBITDA	-26.52	-29.5	-30.51	-22.8	-19.54	Upgrade
D&A For EBITDA	0.13	0.13	0.13	0.16	0.2	Upgrade
EBIT	-26.64	-29.63	-30.64	-22.97	-19.74	Upgrade

Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q